Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
AI- and robotics-powered waste sorting can turn garbage into a valuable source of recovered materials.
Faculty
Clean energy, efficient tech, thoughtful siting, and community input can curb data centers’ environmental and social impacts.
Faculty
ERM part-time lecturer Rajat Baijal breaks down the lessons for risk management from the fall of hedge fund Situational Awareness.
All News
